Search alternatives:
evolveddsssdss. » evolvedddsssdss. (Expand Search)
evolve. » evolved. (Expand Search)
evolves. » evolveds. (Expand Search), evolved. (Expand Search)
evolveddsssdss. » evolvedddsssdss. (Expand Search)
evolve. » evolved. (Expand Search)
evolves. » evolveds. (Expand Search), evolved. (Expand Search)
-
301
General Synthesis of Di-μ-oxo Dimanganese Complexes as Functional Models for the Oxygen Evolving Complex of Photosystem II
Published 2005“…Solutions of the in situ-formed di-μ-oxo dimanganese complexes were characterized by electrospray mass spectrometry, EPR spectroscopy, and UV−visible spectroscopy, and the rates of catalytic oxygen-evolving activity were assayed. …”
-
302
General Synthesis of Di-μ-oxo Dimanganese Complexes as Functional Models for the Oxygen Evolving Complex of Photosystem II
Published 2005“…Solutions of the in situ-formed di-μ-oxo dimanganese complexes were characterized by electrospray mass spectrometry, EPR spectroscopy, and UV−visible spectroscopy, and the rates of catalytic oxygen-evolving activity were assayed. …”
-
303
General Synthesis of Di-μ-oxo Dimanganese Complexes as Functional Models for the Oxygen Evolving Complex of Photosystem II
Published 2005“…Solutions of the in situ-formed di-μ-oxo dimanganese complexes were characterized by electrospray mass spectrometry, EPR spectroscopy, and UV−visible spectroscopy, and the rates of catalytic oxygen-evolving activity were assayed. …”
-
304
General Synthesis of Di-μ-oxo Dimanganese Complexes as Functional Models for the Oxygen Evolving Complex of Photosystem II
Published 2005“…Solutions of the in situ-formed di-μ-oxo dimanganese complexes were characterized by electrospray mass spectrometry, EPR spectroscopy, and UV−visible spectroscopy, and the rates of catalytic oxygen-evolving activity were assayed. …”
-
305
-
306
-
307
-
308
Side-chain moieties from the N-terminal region of Aβ are Involved in an oligomer-stabilizing network of interactions
Published 2018“…Oligomer-defining interactions involving the Aβ peptide N-terminus may be important in production of the neurotoxic forms and thus should not be neglected.…”
-
309
-
310
-
311
-
312
Structural Study of Prolinium/Fumaric Acid Zwitterionic Cocrystals: Focus on Hydrogen-Bonding Pattern Involving Zwitterionic (Ionic) Heterosynthons
Published 2016“…Pharmaceutical compounds are mostly developed as solid dosage forms containing a single crystal form. This implies that the selection of a particular crystal state for a given molecule is an important step for further clinical outlooks. …”
-
313
Structural Study of Prolinium/Fumaric Acid Zwitterionic Cocrystals: Focus on Hydrogen-Bonding Pattern Involving Zwitterionic (Ionic) Heterosynthons
Published 2016“…Pharmaceutical compounds are mostly developed as solid dosage forms containing a single crystal form. This implies that the selection of a particular crystal state for a given molecule is an important step for further clinical outlooks. …”
-
314
Structural Study of Prolinium/Fumaric Acid Zwitterionic Cocrystals: Focus on Hydrogen-Bonding Pattern Involving Zwitterionic (Ionic) Heterosynthons
Published 2016“…Pharmaceutical compounds are mostly developed as solid dosage forms containing a single crystal form. This implies that the selection of a particular crystal state for a given molecule is an important step for further clinical outlooks. …”
-
315
Structural Study of Prolinium/Fumaric Acid Zwitterionic Cocrystals: Focus on Hydrogen-Bonding Pattern Involving Zwitterionic (Ionic) Heterosynthons
Published 2016“…Pharmaceutical compounds are mostly developed as solid dosage forms containing a single crystal form. This implies that the selection of a particular crystal state for a given molecule is an important step for further clinical outlooks. …”
-
316
-
317
Genes involved in the production of secondary metabolites.
Published 2014“…The amino acids predicted to be activated by the different A domains by the antiSMASH analysis are indicated without mentioning whether they are in the D- or L- form. B. The ten genes cluster possibly involved in the biosynthesis of a secondary metabolite. …”
-
318
-
319
-
320